J
Juan C. García-Rubira
Researcher at Hospital Clínico San Carlos
Publications - 114
Citations - 1735
Juan C. García-Rubira is an academic researcher from Hospital Clínico San Carlos. The author has contributed to research in topics: Myocardial infarction & Acute coronary syndrome. The author has an hindex of 20, co-authored 108 publications receiving 1578 citations. Previous affiliations of Juan C. García-Rubira include Centro Nacional de Investigaciones Cardiovasculares.
Papers
More filters
Journal ArticleDOI
Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial
Borja Ibanez,Carlos Macaya,Vicente Sánchez-Brunete,Gonzalo Pizarro,Leticia Fernández-Friera,Alonso Mateos,Antonio Fernández-Ortiz,José Manuel García-Ruiz,Ana García-Álvarez,Andres Iñiguez,Jesús Jiménez-Borreguero,Pedro López-Romero,Rodrigo Fernández-Jiménez,Javier Goicolea,Borja Ruiz-Mateos,Teresa Bastante,M. Arias,José A. Iglesias-Vázquez,Maite D. Rodriguez,Noemí Escalera,Carlos Acebal,José Angel Cabrera,Juan Valenciano,Armando Pérez de Prado,María J. Fernández-Campos,Isabel Casado,Juan C. García-Rubira,Jaime García-Prieto,David Sanz-Rosa,Carlos Cuellas,Rosana Hernández-Antolín,Agustín Albarrán,Felipe Fernández-Vázquez,José M. de la Torre-Hernández,Stuart J. Pocock,Ginés Sanz,Valentin Fuster +36 more
TL;DR: In patients with anterior Killip class II or less anterior ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention, early intravenous metoprolol before reperfusion reduced infarct size and increased left ventricular ejection fraction with no excess of adverse events during the first 24 hours after STEMI.
Journal ArticleDOI
Circadian variations of infarct size in acute myocardial infarction
Aida Suárez-Barrientos,Pedro López-Romero,David Vivas,Francisco Castro-Ferreira,Iván J. Núñez-Gil,Eduardo Franco,Borja Ruiz-Mateos,Juan C. García-Rubira,Antonio Fernández-Ortiz,Carlos Macaya,Borja Ibanez +10 more
TL;DR: Significant circadian oscillations in infarct size were found in patients according to time-of-day of STEMI onset, and may have a significant impact on the interpretation of clinical trials of cardioprotective strategies in STEMI.
Journal ArticleDOI
Long term outcome of patients with postinfarction left ventricular pseudoaneurysm.
Raúl Moreno,E Gordillo,José Luis Zamorano,Carlos Almería,Juan C. García-Rubira,Antonio Fernández-Ortiz,Carlos Macaya +6 more
TL;DR: Long term outcome of patients with postinfarction left ventricular pseudoaneurysm is relatively benign, with a very low risk of fatal rupture, taking into consideration the relatively high risk of stroke, chronic anticoagulant treatment could be considered.
Journal ArticleDOI
Short- and Long-Term Prognostic Relevance of Cardiogenic Shock in Takotsubo Syndrome: Results From the RETAKO Registry
Manuel Almendro-Delia,Iván J. Núñez-Gil,Manuel Lobo,Mireia Andrés,Oscar Vedia,Alessandro Sionis,Ana Martín-García,María Cruz Aguilera,Eduardo Pereyra,Irene Martín de Miguel,Jose Antonio Linares Vicente,Miguel Corbí-Pascual,Xavier Bosch,Oscar Fabregat Andrés,Alejandro Sánchez-Grande Flecha,Alberto Pérez-Castellanos,Javier López Pais,Manuel De Mora Martín,Juan María Escudier Villa,Roberto Martín Asenjo,Marta Guillén Marzo,Ferrán Rueda Sobella,Álvaro Aceña,José María García Acuña,Juan C. García-Rubira,Retako investigators +25 more
TL;DR: CS complicating TTS may constitute a marker of underlying disease severity and could identify a masked heart failure phenotype with increased vulnerability to catecholamine-mediated myocardial stunning.
Journal ArticleDOI
Prognostic impact of atrial fibrillation in acute coronary syndromes: results from the ARIAM registry.
Manuel Almendro-Delia,Maria Jose Valle-Caballero,Juan C. García-Rubira,Blanca Muñoz-Calero,A García-Alcántara,Antonio Reina-Toral,Jose BenItez-Parejo,Rafael Hidalgo-Urbano +7 more
TL;DR: It is suggested that the presence of new-onset AF during ACS is associated with a significant increase in mortality, even after adjusting for confounding variables.